Title: Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
Authors: Onland, Wes ×
Offringa, Martin
Cools, Filip
De Jaegere, Anne P
Rademaker, Karin
Blom, Henry
Cavatorta, Eric
Debeer, Anne
Dijk, Peter H
van Heijst, Arno F
Kramer, Boris W
Kroon, Andre A
Mohns, Thilo
van Straaten, Henrica L
te Pas, Arjan B
Theyskens, Claire
van Weissenbruch, Mirjam M
van Kaam, Anton H #
Issue Date: 2011
Publisher: BioMed Central
Series Title: BMC Pediatrics vol:11 pages:102
Article number: 10.1186/1471-2431-11-102
Abstract: Randomized controlled trials have shown that treatment of chronically ventilated preterm infants after the first week of life with dexamethasone reduces the incidence of the combined outcome death or bronchopulmonary dysplasia (BPD). However, there are concerns that dexamethasone may increase the risk of adverse neurodevelopmental outcome. Hydrocortisone has been suggested as an alternative therapy. So far no randomized controlled trial has investigated its efficacy when administered after the first week of life to ventilated preterm infants.
ISSN: 1471-2431
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Organ Systems (+)
Department of Health and Technology - UC Leuven
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science